These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2514309)

  • 1. The discrepancy between immunocytochemical and biochemical assay of estrogen receptor in breast cancer patients treated by endocrine therapy.
    Toi M; Nakamura T; Wada T; Yamamoto A; Toge T; Niimoto M; Hattori T
    Jpn J Surg; 1989 Nov; 19(6):768-72. PubMed ID: 2514309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study of estrogen receptor assays between immunocytochemical assay using monoclonal antibody and the dextran- coated charcoal method].
    Toi M; Hamada Y; Seto Y; Hisamatsu K; Suehiro S; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3056-62. PubMed ID: 2429620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Present status of endocrine therapy of breast cancer: a surgeon's view].
    Nomura Y
    Gan To Kagaku Ryoho; 1984 May; 11(5):981-8. PubMed ID: 6426405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormone therapy of breast cancer-its role in the treatment of breast cancer].
    Koyama H; Shiba E
    Gan No Rinsho; 1985 Jul; 31(9 Suppl):1177-81. PubMed ID: 2932568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoendocrine compared with endocrine adjuvant therapies for node-negative breast cancer: predictive value of centrally reviewed expression of estrogen and progesterone receptors--International Breast Cancer Study Group.
    Viale G; Regan MM; Maiorano E; Mastropasqua MG; Golouh R; Perin T; Brown RW; Kovács A; Pillay K; Ohlschlegel C; Braye S; Grigolato P; Rusca T; Gelber RD; Castiglione-Gertsch M; Price KN; Goldhirsch A; Gusterson BA; Coates AS
    J Clin Oncol; 2008 Mar; 26(9):1404-10. PubMed ID: 18349391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Influence of endocrine therapy on the proliferation of estrogen (ER) positive cells and ER negative cells of human breast cancer (MCF-7)].
    Noguchi M; Tajiri K; Taniya T; Kumaki T; Miyazaki I
    Nihon Geka Gakkai Zasshi; 1989 May; 90(5):780-5. PubMed ID: 2529423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogen receptor determinations in primary breast cancer. A comparison of a biochemical dextran-coated charcoal and an immunohistological technique.
    von Kleist S; Berling J; Koltzenburg J; Gropp H
    J Cancer Res Clin Oncol; 1988; 114(6):623-7. PubMed ID: 2462564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of estrogen receptors in paraffin-embedded tissue. Techniques and the value in breast cancer treatment.
    Andersen J
    Acta Oncol; 1992; 31(6):611-27. PubMed ID: 1281648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized trial of adjuvant endocrine therapy, chemotherapy, and chemoendocrine therapy for operable breast cancer stratified by estrogen receptors.
    Nomura Y; Tashiro H; Hisamatsu K; Shinozuka K
    Cancer; 1988 Jun; 61(11):2168-75. PubMed ID: 3130175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].
    Jiang Z; Song S; Liu X
    Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):420-2. PubMed ID: 11810777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical measurement of estrogen receptors in breast cancer tissue samples.
    Jonat W; Maass H; Stegner HE
    Cancer Res; 1986 Aug; 46(8 Suppl):4296s-4298s. PubMed ID: 2425947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic usefulness of estrogen receptor immunocytochemical assays for human breast cancer.
    DeSombre ER; Thorpe SM; Rose C; Blough RR; Andersen KW; Rasmussen BB; King WJ
    Cancer Res; 1986 Aug; 46(8 Suppl):4256s-4264s. PubMed ID: 2425944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Content of epidermal growth factor receptor in metastatic breast cancer: its role in endocrine sensitivity prediction.
    Nesković-Konstantinović ZB; Nikolić-Vukosavljević DB; Branković-Magić MV; Mitrovic LB; Spuzić I
    Neoplasma; 2000; 47(2):107-13. PubMed ID: 10985476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principles and indications of endocrine treatment of advanced breast cancer.
    Mouridsen HT; Palshof T
    Recent Results Cancer Res; 1980; 71():112-7. PubMed ID: 7367722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor analyses in breast cancer: comparison of monoclonal immunohistochemical and biochemical methods.
    Søndergaard G; Pedersen KO; Paulsen SM
    Eur J Cancer Clin Oncol; 1989 Oct; 25(10):1425-9. PubMed ID: 2480241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of estrogen receptor assay in cytotoxic chemotherapy in relation to previous endocrine therapy of advanced breast cancer patients.
    Nomura Y; Yamagata J; Kondo H
    Gan; 1979 Aug; 70(4):473-82. PubMed ID: 510847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients.
    Helin HJ; Isola JJ; Helle MJ; Adlercreutz H
    Breast Cancer Res Treat; 1988 Sep; 12(1):67-73. PubMed ID: 3196886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of hormones on proliferation of ER-positive cells and ER-negative cells of human breast cancer (MCF-7).
    Noguchi M; Tajiri K; Taniya T; Kumaki T; Ashikari A; Miyazaki I
    Oncology; 1990; 47(1):19-24. PubMed ID: 2137212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of immunohistochemical estrogen receptor analysis in paraffin-embedded and frozen sections versus that of steroid-binding assays.
    Andersen J; Thorpe SM; King WJ; Rose C; Christensen I; Rasmussen BB; Poulsen HS
    Eur J Cancer; 1990 Apr; 26(4):442-9. PubMed ID: 1694085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of biochemical and immunoenzymatic macromethods and a new immunocytochemical micromethod for assaying estrogen receptors in human breast carcinomas.
    Devleeschouwer N; Faverly D; Kiss R; Legros N; de Launoit Y; Ryckaert C; Andry M; Lenglet G; Paridaens R; Gompel CM
    Acta Cytol; 1988; 32(6):816-24. PubMed ID: 2462316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.